Depression and Suicide
8
2
2
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
13%
1 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (8)
Youth Depression and Suicide Research Network
Cognitive Behavioral Therapy Following Esketamine for Major Depression and Suicidal Ideation for Relapse Prevention
Neural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatment Outcome in Adolescents
Effects of Transcranial Direct Current Stimulation (tDCS) in the Management of Suicidal Ideation
Psychiatric Orders in Psychoanalytic Treatment of ASD
Accelerated Intermittent Theta Burst Stimulation for Depressive Symptoms
Effectiveness of Ketamine for Depression and Suicidal Ideation in the Emergency Department
Biological Triggers of Depression in Pregnancy